BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29847567)

  • 1. Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
    Kigozi E; Kasule GW; Musisi K; Lukoye D; Kyobe S; Katabazi FA; Wampande EM; Joloba ML; Kateete DP
    PLoS One; 2018; 13(5):e0198091. PubMed ID: 29847567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
    Madania A; Habous M; Zarzour H; Ghoury I; Hebbo B
    Pol J Microbiol; 2012; 61(1):23-32. PubMed ID: 22708343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H; Syre H; Kross M; Stavrum R; Ti T; Phyu S; Grewal HM
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GeneChip analysis of resistant Mycobacterium tuberculosis with previously treated tuberculosis in Changchun.
    Zhang MJ; Ren WZ; Sun XJ; Liu Y; Liu KW; Ji ZH; Gao W; Yuan B
    BMC Infect Dis; 2018 May; 18(1):234. PubMed ID: 29788948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
    Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and profiles of drug resistance-conferring mutations in
    Reta MA; Maningi NE; Fourie PB
    Front Public Health; 2024; 12():1356826. PubMed ID: 38566794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.
    Takawira FT; Mandishora RSD; Dhlamini Z; Munemo E; Stray-Pedersen B
    Pan Afr Med J; 2017; 27():145. PubMed ID: 28904673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia.
    Biadglegne F; Tessema B; Rodloff AC; Sack U
    Int J Med Sci; 2013; 10(11):1589-94. PubMed ID: 24046537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
    Kabir S; Junaid K; Rehman A
    Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
    Llerena C; Medina R
    Biomedica; 2017 Jan; 37(1):28-33. PubMed ID: 28527245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates.
    Hamze M; Ismail MB; Rahmo AK; Dabboussi F
    Int J Mycobacteriol; 2015 Sep; 4(3):228-32. PubMed ID: 27649870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.